Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    AcelRx Pharmaceuticals In...

    NASDAQ: ACRX · Real-Time Price · USD
    0.86
    0.06 (7.50%)
    At close: Jan 09, 2024, 10:00 PM

    AcelRx Pharmaceuticals Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a 651K 1.77M 2.82M
    Cost of Revenue
    		 n/a n/a 2.59M 3.75M
    Gross Profit
    		 n/a 651K -820K -935K
    Operating Income
    		 -15.25M -16.89M -20.35M -35.97M
    Interest Income
    		 n/a 6.74M 1.5M 3.16M
    Pretax Income
    		 -13M -10.29M 59.14M -35.09M
    Net Income
    		 -13M -10.29M 47.76M -35.1M
    Selling & General & Admin
    		 8.53M 11.99M 25.67M 30.93M
    Research & Development
    		 6.72M 5.55M 3.34M 4.09M
    Other Expenses
    		 n/a n/a 84.05M n/a
    Operating Expenses
    		 15.25M 17.54M 30.86M 35.03M
    Interest Expense
    		 -394K 134K 1.12M 2.29M
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 15.25M 17.54M 38.4M 38.78M
    Income Tax Expense
    		 n/a n/a 13K 5K
    Shares Outstanding (Basic)
    		 16.16M 14.26M 7.38M 5.99M
    Shares Outstanding (Diluted)
    		 16.16M 14.26M 7.41M 5.99M
    EPS (Basic)
    		 -0.87 -0.00 5.73 -5.86
    EPS (Diluted)
    		 -0.87 -0.00 5.72 -5.86
    EBITDA
    		 -15.25M -9.84M -17.2M -30.83M
    EBIT
    		 n/a -10.42M 65.2M -32.8M
    Depreciation & Amortization
    		 n/a 311K 1.65M 1.97M

    Add to Watchlist